Phase 3 Study of Lumateperone as Adjunct to Antidepressant Therapy for Major Depressive Disorder and Anxious Distress Meets Endpoints - Psychiatric Times

Submitted by Anonymous (not verified) on Sun, 09/21/2025 - 03:09

Phase 3 Study of Lumateperone as Adjunct to Antidepressant Therapy for Major Depressive Disorder and Anxious Distress Meets Endpoints  Psychiatric Times